Targeted changes in the level of IGFBP2 expression in CRC cells reproduced many of the effects conferred by changes in L1 expression in these cells, including increased motility, proliferation in the absence of serum, and enhanced tumorigenesis and liver metastasis [40]. This evidence concerns the gene IGFBP2 and colorectal carcinoma.